http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100490893-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
| filingDate | 2002-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100490893-B1 |
| titleOfInvention | 2-methoxy-1,3,5-triazine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same |
| abstract | The present invention relates to a 2-methoxy-1,3,5-triazine derivative useful as an antiviral agent, and more particularly, to Chemical Formula 1 having an excellent antiproliferative effect of Hepatitis C virus (HCV). The present invention relates to a novel 2-methoxy-1,3,5-triazine derivative, a pharmaceutically acceptable salt thereof, a preparation method thereof and an antiviral pharmaceutical composition comprising the compound as an active ingredient. The novel 2-methoxy-1,3,5-triazine derivatives represented by the general formula (1) according to the present invention have excellent effects of inhibiting the proliferation of hepatitis C virus (HCV) and are less toxic. It can be usefully used as a prophylactic and therapeutic agent for hepatitis.n n n [Formula 1]n n n n n n n n Wherein R represents a heterocyclic carbonyl group or a substituted phenyl group. |
| priorityDate | 2002-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 347.